Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy
  • Project pages
    • Telemedicine BW
    • MDR & IVDR

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Optogenetic cell analysis - 15/05/2023 A young woman at a desk with long brown curls can be seen looking friendly into the camera.

    opto biolabs: how frustration and inventiveness led to the establishment of a company

    When she found she had no suitable illumination devices for her doctoral thesis, Dr. Kathrin Brenker simply created her own customised adapters and founded a company called opto biolabs. Now, Brenker and company co-founder Luis Köbele sell two different types of devices. The main goal is to equip laboratories with illumination technologies that allow optogenetics methods to be used to accelerate development of optogenetic therapeutics.

    https://www.gesundheitsindustrie-bw.de/en/article/news/opto-biolabs-how-frustration-and-inventiveness-led-establishment-company
  • Press release - 08/05/2023

    Automated detection of embryonic developmental defects

    Researchers at the University of Konstanz publish image analysis software that automatically detects and classifies defects of animal development. Thanks to artificial intelligence, "EmbryoNet" outperforms human experts in terms of speed, accuracy and sensitivity.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/automated-detection-embryonic-developmental-defects
  • Press release - 23/03/2023

    Targeted computer modelling to accelerate antiviral drug development

    Effective drugs against viral diseases like COVID-19 are urgently needed now and in the future. The emergence of viral mutants and yet unknown viruses could push vaccines to their limits. The DZIF scientist and bioinformatician Andreas Dräger from the University of Tübingen is working on a computer-based method that can help to accelerate the time-consuming identification and development of antiviral agents. Using a novel analysis technique that…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/computermodellierung-zur-schnelleren-entwicklung-antiviraler-medikamente
  • Cytolytics GmbH - 14/02/2023 Colour photo of Can (left) and Serina (right) Pinar

    Bioinformatics meets medical diagnostics and drug development

    The start-up company Cytolytics from Tübingen has developed a robust and user-friendly software platform that uses machine learning for the automated analysis of cells. This is beneficial in areas such as cancer diagnostics and the development of new pharmaceutically active substances.

    https://www.gesundheitsindustrie-bw.de/en/article/news/bioinformatics-meets-medical-diagnostics-and-drug-development
  • Press release - 30/01/2023

    Digital platform: Producing custom-fit orthoses quickly, resource-efficiently and cost-effectively

    Resource efficiency, time and cost savings are essential topics in the textile and apparel industry. The advantages of digital manufacturing apply not only to fashion, but also to medical textiles. To this end, the German Institutes of Textile and Fiber Research Denkendorf (DITF) have developed a digital platform that can be used to produce precisely fitting flexible textile orthoses in a resource-, time- and cost-efficient manner.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/digitale-plattform-passgenaue-prothesen-schnell-ressourcenschonend-und-kostenguenstig-herstellen
  • Press release - 24/01/2023

    Genome Editing Procedures Optimised

    Heidelberg scientists succeed in boosting the efficiency of CRISPR/Cas9 and related methods and modifying initially inaccessible DNA sequences.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/verfahren-der-genom-editierung-optimiert
  • Press release - 12/01/2023

    “Zone of uncertainty” in the brain influences its ability to form new memories

    Researchers at the University of Freiburg Medical School led by Prof. Dr. Johannes Letzkus and the Max Planck Institute for Brain Research have discovered that a little-studied area of the brain, the "zone of uncertainty" or "zona incerta," communicates with the neocortex in unconventional ways to rapidly control memory formation.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/zone-der-ungewissheit-im-gehirn-beeinflusst-bildung-von-erinnerungen
  • Press release - 06/09/2022

    Biointelligent sensor for measuring viral activity

    Today, genome editing is almost as easy as programming software. However, the generation of viral vectors as initial material is still associated with many expensive and error-prone handling procedures. Viruses are generated via complex biological processes that have to be optimised virus-specifically in order to produce high-quality therapeutics. A new method is needed that simplifies and optimises these processes.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/Biointelligent-sensor-for-measuring-viral-activity
  • Laboratory automation - 29/11/2021 Mixer-16_Mittel_Teaser.jpg

    Reaching the goal quickly and efficiently with the help of artificial intelligence

    Medical research is slow, costly and time-consuming. The system developed by the start-up LABMaiTE could soon change that. With the help of artificial intelligence, it will be possible to automate laboratory experiments and collect and analyse data at the same time.

    https://www.gesundheitsindustrie-bw.de/en/article/news/reaching-goal-quickly-and-efficiently-help-artificial-intelligence
  • Neurodegenerative diseases - 30/09/2021 A computer screen with MRI images of the head, in front of which is a doctor's hand showing her patient the values on a tablet.

    Artificial intelligence enables early diagnosis of dementia

    We are all afraid of neurodegenerative diseases such as Alzheimer's and Parkinson's disease. Yet, therapies are increasingly becoming available. Although they do not cure what causes a disease, they can at least slow down its progression, provided it is diagnosed as early as possible. The Tübingen-based start-up AIRAmed has developed software that uses artificial intelligence to measure and detect changes in the brain long before they…

    https://www.gesundheitsindustrie-bw.de/en/article/news/artificial-intelligence-enables-early-diagnosis-dementia
  • Press release - 09/09/2021

    Machine learning improves biological image analysis

    Scientists use super-resolution microscopy to study previously undiscovered cellular worlds, revealing nanometer-scale details inside cells. This method revolutionized light microscopy and earned its inventors the 2014 Nobel Prize in Chemistry. In an international collaboration, AI researchers from Tübingen have now developed an algorithm that significantly accelerates this technology.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/machine-learning-improves-biological-image-analysis
  • Digitalisation - 04/08/2021 A man holds the examination device towards the face of a seated patient; on the smartphone the photo of the eye background.

    Eye check for all - quick and easy thanks to artificial intelligence

    Many eye diseases are already easily treatable, if they are detected in time. But waiting months for an ophthalmologist’s appointment seems to be the norm - that is, if you can get to see a specialist at all. The Tübingen-based start-up eye2you wants to improve this situation: it has developed a mobile retinal examination device involving a smartphone and AI. It can be used by family doctors, diabetologists and nursing staff and thus help to…

    https://www.gesundheitsindustrie-bw.de/en/article/news/eye-check-all-quick-and-easy-thanks-artificial-intelligence
  • Article - 22/06/2021 Ausschnitt aus der Software von living brain. Patienten erlernen anhand von Übungen mit VR im kritischen Zeitfenster Alltagsaufgaben effektiv.

    Using virtual reality in the clinic to rehabilitate patients with cognitive disorders

    Outdated and inadequate methods of neurological rehabilitation are still being used for patients with neurological diseases or injuries – and what’s more, the treatment is usually too late. This is because cognitive training is especially important in the critical phases when the brain is particularly plastic. The Heidelberg-based company living brain proves that early treatment is possible using an extremely innovative method – with concentrated…

    https://www.gesundheitsindustrie-bw.de/en/article/news/using-virtual-reality-clinic-rehabilitate-patients-cognitive-disorders
  • Article - 14/04/2021 Implantat.jpg

    Calling for quality seal for implants

    Today's seniors are older and more active, which is why implants remain in the body longer and are subjected to greater strain than before. Improved surfaces are expected to ensure that the implants heal and integrate into the bone optimally. In an interview with BIOPRO, Dietmar Schaffarczyk, CEO of Konstanz-based stimOS GmbH, explains why a voluntary quality seal makes sense and gives consumers a better chance of recognising high-quality…

    https://www.gesundheitsindustrie-bw.de/en/article/news/calling-quality-seal-implants
  • Press release - 28/01/2021

    Carl Zeiss Foundation funds Interdisciplinary practice Study at Heidelberg University with the sum of approximately of 4.5 Million Euros

    Can interconnected digital assistance systems enhance the quality of life of people in older age? Scientists in an interdisciplinary research project at Heidelberg University are exploring this question in a representative practice study. The participating researchers want to investigate how well these technical aids can be used and what benefit they achieve.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/carl-zeiss-foundation-funds-interdisciplinary-practice-study-heidelberg-university-sum-approximately-45-million-euros
  • Press release - 09/11/2020

    Making sense of what you see in biomedical images

    Sometimes an image is just an image. Sometimes it gives those who can read it correctly a deeper insight into what they can see. In many scientific disciplines, the key to extracting meaningful information from large three-dimensional images, obtained from X-ray tomography or optical microscopy, is segmentation, a tedious and time-consuming – and therefore error-prone – task if done manually.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/making-sense-what-you-see-biomedical-images
  • Press release - 19/05/2020

    Cyber Valley welcomes five new members to its Start-Up Network

    Five new companies from the Stuttgart/Tübingen region in southwestern Germany have joined the Cyber Valley Start-Up Network. The innovative technologies and products of AmbiGate, Cytolytics, Mojin Robotics, plus10 and Tactai aim to achieve ground-breaking improvements in the fields of public health, manufacturing, and customer service. These start-ups join ten other companies that are already part of the Cyber Valley Start-Up Network.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/cyber-valley-begruesst-fuenf-neue-mitglieder-seinem-start-network
  • Press release - 17/04/2020

    CoroNotes: New app supports medical studies on COVID-19

    Scientists from the Tübingen Competence Center for Machine Learning and physicians from the University Hospital of Tübingen have developed an app that uses anonymous health data to contribute to a better understanding of the novel coronavirus.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/coronotes-neue-app-unterstuetzt-medizinische-studien-zu-covid-19
  • Biotech start-up from Frickenhausen develops chewing gum as test system for bacteria - 19/12/2019

    A medical connoisseur – the tongue as a sensor for infections

    The start-up 3a-diagnostics GmbH from Frickenhausen is developing a gum that can be used both in doctors’ surgeries and at home as a quick and easy diagnostic aid. The sensor in this case is the human tongue. If bacteria are present – due to an inflammation of the teeth or tonsils, for instance – chewing produces a bitter taste and the doctor can quickly initiate the appropriate treatment.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/medizinischer-feinschmecker-die-zunge-als-sensor-fuer-infektionen
  • Dossier - 09/09/2019 Close-up photo of robot with a human-like head, holding up a hand with fingers.

    Artificial intelligence in medicine: assistance for human senses

    There is no way around it. Whether we like it or not, artificial intelligence (AI) has long been part of our lives, in traffic management, marketing campaigns or in the fields of medicine and life sciences. AI is omnipresent, often without us being aware of it. Baden-Württemberg is home to one of the largest AI research consortia in Europe and has recently become one of the European hotspots for this key technology.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/artificial-intelligence-medicine-assistance-human-senses
  • Expert interview - 13/05/2019 Telemedizin: Vitor Vieira (Inova DE) mit einem selbst entwickelten Wearable, einem T-Shirt zur verbesserten Interaktion zwischen Patienten und Kardiologen für fernkontrolliertes Monitoring

    Innovation management in the life sciences – Inova DE provides insights

    Personalized medicine, medical technology, digital health and artificial intelligence are revolutionizing diagnostics and product development. Analyses are becoming faster and more precise, and data volumes can now be networked and used effectively. The goal of improving people's quality of life is within reach, and this will also strengthen Germany’s future viability. However, not every good idea can be turned into a marketable commodity.…

    https://www.gesundheitsindustrie-bw.de/en/article/news/innovation-management-in-the-life-sciences-inova-de-provides-insights
  • Article - 23/04/2019 D50_5948_b.jpg

    How can care infrastructures benefit from digitization?

    The pilot project NeCTra (Networking - Care - Transparency) investigates how care processes within an urban social environment can be improved by using digital technologies. The goal is to bring together all partners and institutions in real time so that people in need of care and those seeking advice receive appropriate support more quickly.

    https://www.gesundheitsindustrie-bw.de/en/article/news/how-can-care-infrastructures-benefit-from-digitization
  • Article - 18/03/2019 European Union flag in the wind.

    EHR and PHR: digital records in the German healthcare system

    EHRs, i.e. electronic health records (German: Patientenakte, ePA), are hailed as the key to increasing the quality of care. The Appointment Service and Supply Act (TSVG), adopted on 14th March 2019, requires the German statutory health insurance funds to provide policyholders with electronic health records from 1st January 2021 onwards.

    https://www.gesundheitsindustrie-bw.de/en/article/news/ehr-and-phr-digital-records-in-the-german-healthcare-system
  • Article - 07/02/2019 Ein Porträtfoto des Mediziners.

    Artificial intelligence in ophthalmology

    Retinal diseases such as age-related macular degeneration (AMD) are now treatable. However, it is hard to predict individual disease progression. A group of researchers at the University Eye Centre in Freiburg are currently developing a new system which is hoped will allay fears and improve therapy planning. The system uses artificial intelligence to predict therapeutic outcome from image and patient data. Initial results are already available.

    https://www.gesundheitsindustrie-bw.de/en/article/news/artificial-intelligence-in-ophthalmology
  • Company profile - 19/12/2018 The photo shows a lateral view of a typical printer with a red blister pack to symbolise the suitability of printers for the production of drugs.

    With DiHeSys into integrated digital healthcare

    The founders and partners of DiHeSys have big ambitions: "We have to build a complete ecosystem around the patient," says Dr. Markus Dachtler, managing director of DiHeSys. The company develops products and services for an industry in transition, provides answers to trends such as personalized medicine, 2D- and 3D-printing technologies and platform technologies. The company’s motto: no isolated solutions, but a comprehensive range of…

    https://www.gesundheitsindustrie-bw.de/en/article/news/with-dihesys-into-integrated-digital-healthcare
  • Company profile - 19/11/2018 The photo shows a monitor with six radiological images.

    CHILI GmbH – teleradiology pioneers

    Teleradiology is the most advanced telemedicine application in Germany. CHILI GmbH from Dossenheim is one of the companies that has contributed to driving the development of teleradiology forward. The company specialises in PACS and teleradiology systems and helps connect clinics and physicians.

    https://www.gesundheitsindustrie-bw.de/en/article/news/chili-gmbh-teleradiology-pioneers
  • Article - 02/10/2018 Microscope image of a kidney section, marked with yellow circles.

    Artificial intelligence in the life sciences: machines as assistants

    Artificial intelligence is currently one of the most innovative issues, but also one of the most controversial research areas. It already has a firm footing in many areas of our everyday life and often we are not even aware of it. Artificial intelligence has long been an integral part of many processes in research and diagnostics in medicine and the life sciences – and it will be even more widely used in the future.

    https://www.gesundheitsindustrie-bw.de/en/article/news/artificial-intelligence-in-the-life-sciences-machines-as-assistants
  • Company profile - 26/07/2018 Screenshot of the pneumonia evid.one app.

    evid - therapy recommendations at a glance

    There are over 700 treatment guidelines in Germany alone, and each is up to several hundred pages long. Can doctors still stay on top of things? A start-up company from Mannheim called evid is developing a software that can retrieve relevant therapy recommendations for individual patients from the huge pile of paperwork. In March 2018, the founding trio won first place of the eHealthForum Freiburg start-up competition.

    https://www.gesundheitsindustrie-bw.de/en/article/news/evid-therapy-recommendations-at-a-glance
  • Article - 03/07/2018 Laboratory technician wearing a white lab coat and data goggles, sitting at a hood, pipetting liquid into a laboratory vessel.

    The digital laboratory is picking up speed

    A new team at the Fraunhofer IPA is developing digital laboratory systems to support industrial partners in planning and managing laboratory processes. This benefits companies in terms of quality assurance, economic efficiency and, notably, ergonomic improvements to the work place.

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-digital-laboratory-is-picking-up-speed
  • Dossier - 06/03/2018 The diagram shows a huge tidal wave with a mighty crest breaking on a person with a bowed head. Along the wave are keywords that reflect the opportunities (optimisation, data management, research, precision medicine) and risks (databases, monitoring) of using big data.

    Big data - the big promise of the new digitised world

    Big data is a widely used buzzword in today's information era. The use of big data in the digital world presents both an opportunity and a risk. Mass data is now used and analysed in almost all areas of life. Even the healthcare sector is undergoing extensive digitisation.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/big-data-the-big-promise-of-the-new-digitised-world
  • Article - 15/01/2018 Schematic showing how a blockchain works.

    Blockchain technology as an opportunity for more transparency and self-determination

    In the healthcare sector, blockchain technology is still in the early stages of development, although it has huge potential in this field. It is expected that patients will particularly benefit from the introduction of a decentralised database for managing and sharing health-related information with treating physicians. Statutory health insurance companies become less important as intermediaries. But how exactly does this technology work?

    https://www.gesundheitsindustrie-bw.de/en/article/news/blockchain-technology-as-an-opportunity-for-more-transparency-and-self-determination
  • Article - 07/12/2017 Screenshot showing the separation of biomolecules. Coloured lines or peaks represent different components: antibody (pink), contaminated with lysozyme (dark blue) and myoglobin (light blue).

    GoSilico: a formula for the industrial purification of biomolecules

    “Stop experimenting – GoSilico” is the motto of a young start-up company from Karlsruhe. The founding team of GoSilico GmbH is causing a furore with a simulation software that would make many laboratory experiments obsolete. The chromatographic separation of biomolecules from organisms, samples and cell cultures can be reliably simulated after just a few starter experiments. This saves time, work, material and costs in pharmaceutical development.

    https://www.gesundheitsindustrie-bw.de/en/article/news/gosilico-a-formula-for-the-industrial-purification-of-biomolecules
  • Press release - 23/05/2017

    TolerogenixX secures seed funding and completes Phase I clinical trial

    TolerogenixX GmbH has developed a patented and clinically tested cell therapy technique for individualised immunosuppression in transplant patients. The technique enables the targeted disabling of undesired reactions caused by the immune system’s defences. As a seed stage investor, High-Tech Gründerfonds (HTGF) will finance this innovative technique and the preparations for Phase II of the clinical trial, which begins in spring 2018. Further…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/tolerogenixx-secures-seed-funding-and-completes-phase-i-clinical-trial
  • Article - 20/04/2017 Gesundheits-App-TrackerDevice-Teaserbild.jpg

    Health app to be integrated into clinical trials

    Questionnaires are a thing of the past, now it is becoming increasingly likely that information for clinical trials will be collected via apps in the future. A new research platform has been developed to prepare patient data transmitted via smartphone applications. Doctors who are carrying out research will thus have access to more accurate results that will also ultimately benefit patients.

    https://www.gesundheitsindustrie-bw.de/en/article/news/health-app-to-be-integrated-into-clinical-trials
  • Article - 12/04/2017 Simone Pöschel using an ImageStream®X device

    Imaging flow cytometry – introducing a new era of imaging

    High-resolution images or quantifiable results? Up until now, researchers usually had to choose. All this has now changed thanks to a single device known as an imaging flow cytometer that combines fluorescence microscopy and flow cytometry. The new device gives new insights into complex biological phenomena in cells. It is available for research purposes at the Research Centre for Women’s Health at the University Hospital of Tübingen, which…

    https://www.gesundheitsindustrie-bw.de/en/article/news/imaging-flow-cytometry-introducing-a-new-era-of-imaging
  • Prenatal diagnosis - 23/03/2017 A transparent plastic disk and a microscope slide that is held with a pair of tweezers.

    Microdroplets for safe and rapid prenatal diagnoses

    Although the methods used to carry out amniocentesis are quite sophisticated, there is still a 0.5 percent risk of miscarriage following the intervention. Therefore, an EU-funded project called AngeLab is developing a rapid test that only requires a blood sample of the mother rather than amniotic fluid. The test yields information on the genetic health of the foetus within only a few hours. As part of the project, researchers from the…

    https://www.gesundheitsindustrie-bw.de/en/article/news/microdroplets-for-safe-and-rapid-prenatal-diagnoses
  • Article - 20/03/2017

    Expansion of the de.NBI, the German Network for Bioinformatics Infrastructure

    The German Network for Bioinformatics Infrastructure, de.NBI for short, is a successful model for infrastructures in the life sciences and biomedicine that is currently being expanded. The network, which was established in 2015, will benefit from more hardware, more staff, more projects and its own cloud. It has also joined the European ELIXIR network.

    https://www.gesundheitsindustrie-bw.de/en/article/news/expansion-of-the-denbi-the-german-network-for-bioinformatics-infrastructure
  • Diagnosis - 13/02/2017 Tomes GmbH team at the Elevator Pitch BW in Freiburg.

    Idana: an anamnesis software that asks the right questions

    Studies have shown that communication between doctors and patients is very important for doctors to be able to give a precise diagnosis and to increase patient acceptance of therapy. Unfortunately, doctors often do not have the time for in-depth conversations with their patients. A new anamnesis software called Idana looks set to change this situation. The software tailors questions specifically to individual patients and helps treating doctors…

    https://www.gesundheitsindustrie-bw.de/en/article/news/idana-an-anamnesis-software-that-asks-the-right-questions
  • Article - 26/01/2017 The photo shows Johannes Englert, pointing towards the online login page of the Baden-Württemberg Cancer Register.

    Clinical cancer registration to improve patient treatment and care

    Germany records around 500,000 new cases of cancer every year. The number is steadily growing, mainly due to an ageing population that leads to an increased risk of cancer. The German government is planning to establish clinical cancer registries in all German states so that all cancer patients receive the best possible treatment. In Baden-Württemberg, all new cancer cases are already recorded. However, the data are still not as comprehensive as…

    https://www.gesundheitsindustrie-bw.de/en/article/news/clinical-cancer-registration-to-improve-patient-treatment-and-care
  • Article - 22/11/2016 Eine Maschine im Biomechanik-Labor, die Druck und Bewegung erzeugt.

    Research on the durability and longevity of artificial joints

    In Germany alone, several hundred thousand patients are given an artificial hip, knee or shoulder joint every year. Prof. Dr. Jan Philippe Kretzer and his team of researchers in the Laboratory of Biomechanics and Implant Research at the University Hospital in Heidelberg are studying what limits the longevity of implants and how durability can be improved.

    https://www.gesundheitsindustrie-bw.de/en/article/news/research-on-the-durability-and-longevity-of-artificial-joints
  • Imaging Methods - 03/11/2016 Dargestellt sind vier unterschiedliche MRT-Querschnitte des menschlichen Gehirns.

    Using sugar to detect brain tumours

    An international team of researchers is developing an MRI-based method for the early detection of human brain tumours. The method is called CEST-MRI and it detects elevated glucose concentrations in humour tissues, quantitatively and at high spatial resolution. It does not expose patients to radiation, is non-invasive and relatively inexpensive.

    https://www.gesundheitsindustrie-bw.de/en/article/news/using-sugar-to-detect-brain-tumours
  • High-tech - 20/10/2016 Man standing in front of a robot.

    Industry 4.0 in the medical technology and pharmaceutical industry sectors

    The digitalisation of industry affects the entire value chain. From individual products to digitising workflows in companies and connecting companies with clients and service providers via the Internet of Things – Industry 4.0 makes completely new manufacturing processes possible and requires new and specific business models.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/industry-40-in-the-medical-technology-and-pharmaceutical-industry-sectors
  • Article - 27/07/2016 The left part of the schematic shows the phylogenetic tree of Ebola viruses. The different regions where the Ebola viruses were found are represented in different colours. The right side shows a map of West Africa; the regions where the viruses used for the analysis were found have the same colour as the respective lines in the tree.

    “Open science“ – a successful recipe for combating viruses

    Danger identified, danger averted – the better the dynamic changes of the viral genome are understood, the better the spread of the pathogens can be predicted, thus enabling more efficient countermeasures to be taken. A team of researchers from Tübingen and Seattle is developing an open source online platform that maps the evolution of viruses and identifies dangerous developments.

    https://www.gesundheitsindustrie-bw.de/en/article/news/open-science-a-successful-recipe-for-combating-viruses
  • Company profile - 18/07/2016 A tablet computer and a smartphone with a medical image.

    mbits imaging GmbH – mobile app in the field of radiology

    Trying to get a second opinion from a medical colleague who is at home preparing dinner may be quite a challenge, especially when the colleague does not have access to the necessary image data. This has now become easier in the field of radiology thanks to a mobile app called mRay, which provides a reliable way for radiologists to share medical images on mobile devices.

    https://www.gesundheitsindustrie-bw.de/en/article/news/mbits-imaging-gmbh-mobile-app-in-the-field-of-radiology
  • Company profile - 05/07/2016 Logo_final.jpg

    HS-Analysis GmbH – using digital histology to develop new drugs

    The idea of analysing tissue samples automatically sounds more of a pipe dream than anything else. However, it already happens. HS-Analysis GmbH's ability to interpret tissue samples automatically is driving new drug development a decisive step forward.

    https://www.gesundheitsindustrie-bw.de/en/article/news/hs-analysis-gmbh-using-digital-histology-to-develop-new-drugs
  • Article - 12/05/2016 Grey, three-dimensional molecule model surrounded by red RNA sequences.

    Novel method for predicting the spatial structure of biomolecules

    Biomolecules can only fulfil their functions in the cell when they fold into a characteristic native three-dimensional structure. Knowing this structure is not only of paramount importance for basic research, but also for medicine and pharmacology. Scientists from the Karlsruhe Institute of Technology (KIT) have therefore developed a simple method to predict the three-dimensional structure of biomolecules from the analysis of readily available…

    https://www.gesundheitsindustrie-bw.de/en/article/news/novel-method-for-predicting-the-spatial-structure-of-biomolecules
  • Article - 21/12/2015 Computer model of the heart shown in different colours.

    Using a heart simulator for optimal therapy

    A realistic computer model of the human heart is expected to make treating heart diseases more effective: doctors will be able to test medicines and surgical techniques on the computer heart and determine the most effective therapy. Olaf Dössel, director of the Institute of Biomedical Engineering at the Karlsruhe Institute of Technology, believes that his team's heart model is among the top five in the world.

    https://www.gesundheitsindustrie-bw.de/en/article/news/using-a-heart-simulator-for-optimal-therapy
  • Press release - 09/12/2015 Htgf

    New financing conditions from High-Tech Gründerfonds

    High-Tech Gründerfonds (HTGF) is raising its seed investment to €600k and lowering interest rates by 4%. This is in response to changing requirements in the start-up and venture capital scene, as well as current interest rate trends. The package of measures will be effective from January 1, 2016.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-financing-conditions-from-high-tech-gruenderfonds
  • Article - 14/10/2015 Photo of a team of scientists standing at a desk and planning an experiment.

    High-throughput technologies and bioinformatics from a single source – the Quantitative Biology Center (QBiC)

    “Omics” is a current buzz word used to describe comprehensive investigations in many areas of the life sciences. In practice, omics refers to fields of scientific study that involve a huge number of experiments and even more data. Evaluating and managing all the data within a fixed period is a huge challenge for most researchers working on their own. It was to address these issues that the Quantitative Biology Center – QBiC for short – was…

    https://www.gesundheitsindustrie-bw.de/en/article/news/high-throughput-technologies-and-bioinformatics-from-a-single-source-the-quantitative-biology-center-qbic
  • Article - 29/06/2015 Neher sitting in front of his computer, pointing at a drawing on the screen.

    How can influenza virus prediction be improved?

    Every February, the World Health Organisation (WHO) publishes recommendations on the composition of influenza virus vaccines for use in the upcoming influenza season. The WHO’s decision is based on observations and laboratory tests as well as experience and intuition. The particular type of influenza virus that is likely to be circulating in a given season has previously been mainly a matter of speculation. Richard Neher from the Max Planck…

    https://www.gesundheitsindustrie-bw.de/en/article/news/how-can-influenza-virus-prediction-be-improved

Page 1 / 3

sb_search.block.search_result.other.pages

  • 1
  • 2
  • 3
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Newsletter abonnieren

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.gesundheitsindustrie-bw.de/en/search